Dr. Ulrike Banning Appointed Business Unit Director Medical Knowledge Solutions at Vidal MMI
Vidal MMI is strengthening its leadership team with an experienced healthcare and pharmaceutical industry expert. Her focus is on the intersection of data, digital products, and commercial strategy. Since September 1, 2026, Dr. Ulrike Banning, in her role as Business Unit Director Medical Knowledge Solutions, has been responsible for the strategic and operational development of the business unit. Her area of responsibility includes the established brands Gelbe Liste Pharmindex and rehakliniken.de. Gelbe Liste provides medical information and services for physicians, pharmacies, other healthcare professionals, and the pharmaceutical industry. rehakliniken.de supports patients in finding suitable rehabilitation services.
With the appointment of Dr. Ulrike Banning, Vidal MMI is further strengthening its Medical Knowledge Solutions business unit and investing in the continued development of medical information and digital services for healthcare professionals and the pharmaceutical industry.
As regulatory requirements increase, data volumes grow, and healthcare becomes increasingly digital, reliable, up-to-date, and practical information is becoming ever more important. The company aims to further expand its offerings for healthcare professionals and pharmaceutical customers, develop new solutions, and strengthen the market position of the Gelbe Liste Pharmindex and rehakliniken.de brands.
Dr. Ulrike Banning brings more than 15 years of experience in the healthcare and pharmaceutical industry. Most recently, she served at IQVIA Germany as Director Business Development and Head of OneKey and Marketing Services. Prior to that, she held various positions in strategy, market analytics, business planning, and consulting.
“With Dr. Ulrike Banning, we are welcoming a leader who combines scientific expertise, deep market knowledge, and many years of experience in the healthcare sector,” says Michael Schösser, Managing Director of Vidal MMI.
“She is a recognized expert in medical information, business development, and healthcare strategy. In her new role, she will help us further develop our offerings for healthcare professionals and the pharmaceutical industry. At the same time, her appointment strengthens our Medical Knowledge Solutions business unit. Our goal is to expand Gelbe Liste Pharmindex and rehakliniken.de and continue providing our customers with relevant solutions for an increasingly digital healthcare environment.”
Dr. Ulrike Banning adds :
“Reliable medical information is the foundation for informed decision-making in healthcare. I look forward to working with the team to further develop innovative solutions for physicians, pharmacies, other healthcare professionals, and our pharmaceutical customers, while continuing to strengthen Vidal MMI’s strong market position.”
